Chat with us, powered by LiveChat

Loading...

HLA Typing For Transplant Market Report

RA00323

HLA Typing for Transplant Market, by Technology (Non-Molecular Assay, Molecular Assay, Next Generation Sequencing, Sanger’s Sequencing), Product (Instruments, Reagents & Consumables, Software & Services), Application (Diagnostics and Research), End-User (Hospitals, Academic & Research Institutes, Commercial Service Providers): Global Opportunity Analysis and Industry Forecast, 2020–2027

RA00323

Pages: 180

May 2020

COVID-19

pandemic has shown to have an enormous impact on most
industries.

Click Here to access our comprehensive analysis of the

Impact of covid-19 on HLA Typing for Transplant Market

The global HLA typing for the transplant market will witness significant growth due to a rise in the amount of transplant procedures and an increase in technological advancements in the field of HLA typing.

HLA Typing for Transplant Market, Analysis:

Human leukocyte antigen (HLA) typing is often used to match blood cells or bone marrow transplant of patient’s with donors. As transplant complications increase, there is a growing urgency to balance the viability of organ transplantation before the surgery to prevent any damage. Matching HLA assists to grow and develop new blood cells and eliminates the risk of adverse effects after transplantation.

Growth in research & development is expected to drive the global HLA typing for the transplant market

Increasing R&D activities in the pharmaceutical and biotechnology industry are attributing the market growth for the global HLA typing for the transplant market. An increasing number of resources invested by the government, as well as the private business firms in the global HLA typing market, are equally contributing towards the market growth. 

Unfavorable policy for an organ transplant is anticipated to restrain the growth of global HLA typing for the transplant market

Strict government regulations for organ donations and transplantation could hamper market growth. In addition, organ transplant devices are very expensive, and there are only a few organ donations and transplantation centers, these factors restrain the growth of the global HLA typing for the transplant market.

Technological innovations are anticipated to create enormous opportunities for global HLA typing for the transplant market

Technological advancements will further create several opportunities for propelling development in the global HLA typing for the transplant market. Advancement in health care facilities around developing countries poses significant business growth prospects for the market. In addition, growing public-private investment for product innovation is also anticipated to generate enormous opportunities for the market.

HLA Typing for Transplant Market, by Technology:

The molecular assay will be most lucrative till 2027

By technology, the HLA typing for the transplant market is divided into the non-molecular assay, molecular assay, next-generation sequencing, and sanger’s sequencing. Amongst these, molecular assay dominates the market share and is expected to continue till 2027. This is due to various benefits offered by molecular assays such as small processing time, high procedural efficiency, multi-sample test, and real-time data interpretation.

HLA Typing for Transplant Market, by Product & Services:

Instruments segment will be most lucrative till 2027

By product & service, the HLA typing for the transplant market is segmented into instruments, reagents & consumables, and software & services. Out of these, the instrument segment has the largest market share attributing to the rising usage of developed instruments, which assists in providing better and accurate results. 

HLA Typing for Transplant Market, by Applications:

Diagnostic application is estimated to dominate the HLA typing for transplant market 

By application, the HLA typing for the transplant market is classified into diagnostics and research. Diagnostic application is used to match organ and transplantation donors with patients. It has the largest market share, as this technique is used commonly. In addition, an increasing number of organ donations and transplants will contribute towards market growth.

HLA Typing for Transplant Market, by End-Users:

Hospital is estimated to be the highest growing till 2027

By end-users, the HLA typing for the transplant market is bifurcated into hospitals, academic & research institutes, and commercial service providers. Amongst these, the hospital sector dominated the market share and is anticipated to continue until 2027. The hospital sector leads the market due to the availability of advanced medical equipment and skilled personnel that enables treating patients efficiently and provides accurate results on time. HLA typing for transplant is more commonly used in hospitals and health sectors than other end-users owing to its increasing number of the patient count with the rising population.   

HLA Typing for Transplant Market, by Region:

Asia-Pacific region will have lucrative opportunities for the market investors

The global HLA typing for the transplant market is analyzed across North America, Europe, Asia-Pacific, and LAMEA regions. North America dominates the market share of the HLA typing for the transplant market owing to the increasing number of organ transplant procedures and rising life expectancy rates. Asia-Pacific is anticipated to be the fastest-growing region due to the increasing adoption of advanced technology and medical devices. 

To explore more about Global HLA Typing for Transplant Market, get in touch with our analysts here.

https://www.researchdive.com/connect-to-analyst/323

Key Participants in the Global HLA Typing for Transplant Market:

Merger & acquisition and advanced product development are the frequent strategies followed by the market players

Key Participants in the Global HLA Typing for Transplant Market

Some of the major key players in the global HLA typing for transplant market are Thermo Fisher Scientific, Qiagen, Illumina Inc., CareDx Inc., Immucor Inc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc., Luminex Co., Biofortuna, and others.

Market Players prefer inorganic growth strategies to expand into local markets.HLA typing for transplant market players are emphasizing more on merger & acquisition and advanced product development. These are the various strategies followed by established organizations. To emphasize more on the competitor analysis of market players,Porter’s five forces model is explained in the report.

Aspect

Particulars

  Historical Market Estimations

  2018-2019

  Base Year for Market Estimation

  2019

  Forecast timeline for Market Projection

  2020-2027

  Geographical Scope

  North America, Europe, Asia-Pacific, LAMEA

  Segmentation by Technology

  • Non-Molecular Assay
  • Molecular Assay
  • Next Generation Sequencing
  • Sanger’s Sequencing

  Segmentation by Product & Service

  • Instruments
  • Reagents & Consumables
  • Software & Services

  Segmentation by Application

  • Diagnostics
  • Research

  Segmentation by End-User

  • Hospitals
  • Academic & Research Institutes
  • Commercial Service Providers

  Key Countries Covered

U.S., Canada, Germany, France, Spain,

Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

  Key Companies Profiled

  • Thermo Fisher Scientific
  • Qiagen
  • Illumina Inc.
  • CareDx Inc.
  • Immucor Inc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Luminex Co.
  • Biofortuna

Source: Research Dive Analysis


FREQUENTLY ASKED QUESTIONS?
 

A. Thermo Fisher Scientific, Qiagen, and Illumina Inc. are some of the key players in the global HLA typing for the transplant market.

A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.

A. Technological advancements, product development, along with joint ventures, are the key strategies opted by the operating companies in this market.

A. CareDx Inc., Immucor Inc and Bio-Rad Laboratories Inc. are the companies investing more in R&D activities for developing new products and technologies.

Research Methodology

Purchase Options

Enquire To Buy

Personalize this research

  • Triangulate with your own data
  • Get Data as per your format and defination
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed